Management of Coronary Calcium Score 238
For a coronary artery calcium (CAC) score of 238, you should initiate high-intensity statin therapy and consider aspirin 81 mg daily. 1
Risk Stratification
A CAC score of 238 places this patient in the intermediate-to-high risk category (CAC 100-400), corresponding to a 10-20% 10-year ASCVD risk 2. This score indicates established atherosclerotic plaque burden and warrants aggressive preventive therapy.
Pharmacotherapy Recommendations
Statin Therapy
- Initiate statin therapy immediately - both the National Lipid Association (NLA) and Society of Cardiovascular Computed Tomography (SCCT) explicitly recommend statin therapy for CAC ≥100 1
- Target LDL-C reduction of ≥30% for intermediate risk, though ≥50% reduction provides optimal ASCVD risk reduction 3
- The 2019 ACC/AHA guidelines support statin initiation when CAC is 100 or higher or in the 75th percentile or higher 3
Aspirin
- Consider aspirin 81 mg daily - the NLA and SCCT guidelines support aspirin for CAC >100 1
- The Australian/New Zealand position suggests modest benefit for aspirin in the CAC 100-400 range 2
Key Clinical Considerations
Why This Score Matters
- CAC scores >0 portend coronary events, with risk increasing proportionally to the score 4
- At any CAC score >0, myocardial infarctions can occur 5
- A score of 238 represents months of progressive cholesterol plaque accumulation requiring intervention 5
Lifestyle Modifications
Optimal diet and lifestyle measures form the foundation of primary prevention and should be emphasized alongside pharmacotherapy 2. This includes:
- Dietary modification to reduce atherogenic cholesterol
- Regular physical activity
- Smoking cessation if applicable
- Weight management
Repeat Testing
Do not routinely repeat CAC scanning in patients with positive calcium scores 2. The current score of 238 already provides sufficient information to guide aggressive preventive therapy. Repeat scanning at 5 years may be considered only if there is clinical uncertainty about continuing therapy, though this is generally not recommended for established positive scores.
Common Pitfalls to Avoid
- Don't delay treatment - the response to statin therapy improves with shorter duration of exposure to atherogenic cholesterol 5
- Don't undertreat - while some guidelines distinguish between CAC 100-300 and >300, a score of 238 warrants at minimum moderate-intensity statin therapy, with consideration for high-intensity based on overall risk profile
- Don't order stress testing or coronary angiography unless clinically relevant symptoms develop - the NLA specifically advises against invasive testing for high CAC scores in asymptomatic patients 1
Evidence Strength
The recommendations are based on Class IIa, Level B evidence from major guidelines 3, with strong consensus across the NLA, SCCT, ACC/AHA, and international societies 1, 2. The 2023 NLA guidelines represent the most comprehensive and recent guidance, explicitly categorizing CAC as the best predictor of 5-10 year ASCVD event risk 1.